C-PAP/PHEN/PROST/Atrop 150/7 recalled over sterility concerns
- Recall date
- July 26, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Pharmacy Plus, Inc. dba Vital Care Compounder recalls C-PAP/PHEN/PROST/Atrop 150/7.5 (Papaverine 150mg/Phentolamine 7.5mg/Prostaglandin 75mcg/Atropine 1mg injection), 10 ml…
- Recall number
- D-1547-2016
- FDA classification
- Class II
- Brand / firm
- Pharmacy Plus, Inc. dba Vital Care Compounder
- Sold / distributed
- MS
Why it was recalled
Lack of Assurance of Sterility
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
C-PAP/PHEN/PROST/Atrop 150/7.5 (Papaverine 150mg/Phentolamine 7.5mg/Prostaglandin 75mcg/Atropine 1mg injection), 10 ml vial containing 5.9ml solution, Rx, Vital Care Compounder, Hattiesburg, MS
Get recall alerts
Free email alert whenever Pharmacy Plus, Inc. dba Vital Care Compounder has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Pharmacy Plus, Inc. dba Vital Care Compounder